Master the Art of Pitching – Elevate Your Startup Game

Are you an entrepreneur or innovator with a game-changing startup idea? Want to communicate it with confidence, clarity, and impact?

Join Venture Cup and Flemingsberg Science Foundation for a high-energy, hands-on pitch workshop led by Malcolm Larri, a renowned pitch coach who has trained founders across the Nordics and beyond.

– Learn how to craft a compelling pitch
– Boost your confidence and presence
– Stand out in a crowded startup landscape
– Receive expert feedback to sharpen your delivery

Venture Cup STARTUP competition is open—this workshop is your chance to refine your pitch and take the stage at Sweden’s biggest startup event!

Bonus for Flemingsberg-based entrepreneurs! Apply for the Flemingsberg Science Award and compete for 10,000 SEK + a 3-month membership at Innovation Station—the hub for startups and innovators.

Date & Time: 12 March 2025 | 12:00 – 13:00
Location: Innovation Station Flemingsberg

Lunch sandwiches included

Spots are limited—sign up now and take your pitch to the next level!

Sign up today >

Portabel Health: Crowned Winner of Flemingsberg Science STARTUP Award 2025

Quickly finding the right personnel is one of the healthcare sector’s major challenges, especially in times of staff shortages and increasing demands for efficiency. Portabel Health offers a modern solution to these problems through a digital platform that makes it easy for care providers to access qualified nurses and healthcare professionals.

Press Start: The Game Hub in Flemingsberg – Finally!

On April 24th, after just two months of hard work, it was finally time for the kick-off for the game cluster Press Start. The initiative is led by Drivhuset, in close collaboration with Flemingsberg Science Foundation and Södertörn University's Innovation Station.

AlzeCure Pharma – a hope in the fight against Alzheimer’s

Neurological diseases and the pain area are struggling with great medical needs, including the lack of broad-spectrum drugs. Those are gaps in the market that AlzeCure Pharma wants to fill, and they are well on their way. They recently received a grant from the European Innovation Council (EIC) to finance a clinical phase 2 study of the drug candidate NeuroRestore ACD856 for Alzheimer’s disease.

Previous 345 Next